Ortin End Period Cash Flow vs Free Cash Flow Analysis

ORTINLAB

19.63 0.00 0.00%

Ortin Laboratories financial indicator trend analysis is much more than just breaking down Ortin Laboratories prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ortin Laboratories is a good investment. Please check the relationship between Ortin Laboratories End Period Cash Flow and its Free Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ortin Laboratories End Period Cash Flow account and Free Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Ortin Laboratories' End Period Cash Flow and Free Cash Flow is -0.37. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Ortin Laboratories Limited, assuming nothing else is changed. The correlation between historical values of Ortin Laboratories' End Period Cash Flow and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Ortin Laboratories Limited are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., Ortin Laboratories' End Period Cash Flow and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.37

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Ortin Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ortin Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of November 28, 2024, Selling General Administrative is expected to decline to about 1.5 M. The current year's Tax Provision is expected to grow to about (144.5 K)

	2021	2022	2023	2024 (projected)
Interest Expense	7.9M	4.0M	4.8M	4.6M
Depreciation And Amortization	2.9M	2.5M	2.3M	2.2M

Interest Expense Depreciation And Amortization

Ortin Laboratories fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Receivables	Current Deferred Revenue	Short Term Debt	Short Term Investments	Other Liab
Common Stock Shares Outstanding		0.33	0.29	0.08	0.33	0.38	0.47	0.36	0.39	0.24	-0.76	0.45	-0.04	-0.77	-0.04	0.28	-0.7	-0.16	0.3	0.25	0.55	-0.09	-0.04	0.07	0.18	-0.12
Total Assets	0.33		0.88	0.39	0.98	0.91	0.84	0.88	0.7	0.9	-0.4	0.8	-0.09	-0.41	0.65	0.93	-0.74	-0.14	0.99	0.98	0.87	0.85	-0.32	0.86	-0.17	0.86
Short Long Term Debt Total	0.29	0.88		0.26	0.79	0.95	0.81	1.0	0.82	0.61	-0.43	0.83	0.05	-0.45	0.87	0.87	-0.71	-0.07	0.84	0.82	0.86	0.64	-0.2	0.96	-0.17	0.84
Other Current Liab	0.08	0.39	0.26		0.46	0.14	0.12	0.24	0.21	0.53	0.0	0.07	0.1	-0.01	0.2	0.58	-0.17	0.16	0.45	0.47	0.14	0.28	-0.96	0.25	-0.09	0.31
Total Current Liabilities	0.33	0.98	0.79	0.46		0.83	0.78	0.79	0.63	0.96	-0.33	0.71	-0.15	-0.35	0.52	0.91	-0.72	-0.16	1.0	0.99	0.82	0.88	-0.39	0.78	-0.19	0.81
Total Stockholder Equity	0.38	0.91	0.95	0.14	0.83		0.94	0.96	0.71	0.66	-0.58	0.93	0.02	-0.6	0.75	0.81	-0.71	-0.09	0.86	0.82	0.9	0.68	-0.06	0.88	-0.09	0.81
Property Plant And Equipment Net	0.47	0.84	0.81	0.12	0.78	0.94		0.84	0.47	0.64	-0.73	0.97	0.02	-0.75	0.53	0.67	-0.65	-0.09	0.79	0.72	0.83	0.59	-0.08	0.72	-0.11	0.67
Net Debt	0.36	0.88	1.0	0.24	0.79	0.96	0.84		0.81	0.6	-0.51	0.86	0.04	-0.53	0.85	0.86	-0.72	-0.09	0.83	0.8	0.87	0.61	-0.19	0.94	-0.14	0.81
Retained Earnings	0.39	0.7	0.82	0.21	0.63	0.71	0.47	0.81		0.46	-0.3	0.52	-0.15	-0.31	0.75	0.8	-0.69	-0.24	0.67	0.7	0.74	0.42	-0.09	0.74	0.1	0.57
Accounts Payable	0.24	0.9	0.61	0.53	0.96	0.66	0.64	0.6	0.46		-0.21	0.55	-0.22	-0.22	0.33	0.82	-0.6	-0.19	0.94	0.94	0.67	0.88	-0.48	0.62	-0.24	0.72
Cash	-0.76	-0.4	-0.43	0.0	-0.33	-0.58	-0.73	-0.51	-0.3	-0.21		-0.71	0.11	1.0	-0.16	-0.31	0.43	0.27	-0.33	-0.25	-0.49	0.03	-0.02	-0.22	-0.21	-0.04
Non Current Assets Total	0.45	0.8	0.83	0.07	0.71	0.93	0.97	0.86	0.52	0.55	-0.71		0.15	-0.72	0.63	0.64	-0.68	-0.03	0.74	0.65	0.84	0.52	-0.06	0.76	-0.18	0.68
Non Currrent Assets Other	-0.04	-0.09	0.05	0.1	-0.15	0.02	0.02	0.04	-0.15	-0.22	0.11	0.15		0.09	0.22	-0.13	-0.16	0.86	-0.12	-0.16	0.13	-0.14	-0.11	0.09	-0.25	0.12
Cash And Short Term Investments	-0.77	-0.41	-0.45	-0.01	-0.35	-0.6	-0.75	-0.53	-0.31	-0.22	1.0	-0.72	0.09		-0.18	-0.33	0.45	0.26	-0.35	-0.27	-0.51	0.01	-0.02	-0.23	-0.2	-0.06
Non Current Liabilities Total	-0.04	0.65	0.87	0.2	0.52	0.75	0.53	0.85	0.75	0.33	-0.16	0.63	0.22	-0.18		0.72	-0.43	0.03	0.6	0.59	0.61	0.47	-0.14	0.88	-0.16	0.79
Inventory	0.28	0.93	0.87	0.58	0.91	0.81	0.67	0.86	0.8	0.82	-0.31	0.64	-0.13	-0.33	0.72		-0.65	-0.18	0.93	0.94	0.75	0.72	-0.48	0.83	-0.09	0.8
Other Current Assets	-0.7	-0.74	-0.71	-0.17	-0.72	-0.71	-0.65	-0.72	-0.69	-0.6	0.43	-0.68	-0.16	0.45	-0.43	-0.65		-0.05	-0.72	-0.69	-0.93	-0.46	0.14	-0.62	0.25	-0.5
Other Stockholder Equity	-0.16	-0.14	-0.07	0.16	-0.16	-0.09	-0.09	-0.09	-0.24	-0.19	0.27	-0.03	0.86	0.26	0.03	-0.18	-0.05		-0.15	-0.17	0.04	-0.09	-0.14	0.01	-0.09	0.12
Total Liab	0.3	0.99	0.84	0.45	1.0	0.86	0.79	0.83	0.67	0.94	-0.33	0.74	-0.12	-0.35	0.6	0.93	-0.72	-0.15		0.99	0.84	0.88	-0.38	0.82	-0.19	0.85
Total Current Assets	0.25	0.98	0.82	0.47	0.99	0.82	0.72	0.8	0.7	0.94	-0.25	0.65	-0.16	-0.27	0.59	0.94	-0.69	-0.17	0.99		0.8	0.89	-0.38	0.81	-0.16	0.85
Common Stock	0.55	0.87	0.86	0.14	0.82	0.9	0.83	0.87	0.74	0.67	-0.49	0.84	0.13	-0.51	0.61	0.75	-0.93	0.04	0.84	0.8		0.63	-0.08	0.79	-0.16	0.71
Net Receivables	-0.09	0.85	0.64	0.28	0.88	0.68	0.59	0.61	0.42	0.88	0.03	0.52	-0.14	0.01	0.47	0.72	-0.46	-0.09	0.88	0.89	0.63		-0.23	0.73	-0.29	0.87
Current Deferred Revenue	-0.04	-0.32	-0.2	-0.96	-0.39	-0.06	-0.08	-0.19	-0.09	-0.48	-0.02	-0.06	-0.11	-0.02	-0.14	-0.48	0.14	-0.14	-0.38	-0.38	-0.08	-0.23		-0.22	0.3	-0.26
Short Term Debt	0.07	0.86	0.96	0.25	0.78	0.88	0.72	0.94	0.74	0.62	-0.22	0.76	0.09	-0.23	0.88	0.83	-0.62	0.01	0.82	0.81	0.79	0.73	-0.22		-0.3	0.93
Short Term Investments	0.18	-0.17	-0.17	-0.09	-0.19	-0.09	-0.11	-0.14	0.1	-0.24	-0.21	-0.18	-0.25	-0.2	-0.16	-0.09	0.25	-0.09	-0.19	-0.16	-0.16	-0.29	0.3	-0.3		-0.31
Other Liab	-0.12	0.86	0.84	0.31	0.81	0.81	0.67	0.81	0.57	0.72	-0.04	0.68	0.12	-0.06	0.79	0.8	-0.5	0.12	0.85	0.85	0.71	0.87	-0.26	0.93	-0.31

Click cells to compare fundamentals

Ortin Laboratories Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Ortin Stock

Balance Sheet is a snapshot of the financial position of Ortin Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Ortin Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ortin Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ortin currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ortin End Period Cash Flow vs Free Cash Flow Analysis

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Free Cash Flow

Ortin Laboratories fundamental ratios Correlations

Ortin Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Other Information on Investing in Ortin Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Current Liabilities
Total Current Assets	+ 0.99	Total Liab

Current Deferred Revenue	- 0.96	Other Current Liab
Common Stock	- 0.93	Other Current Assets
Cash And Short Term Investments	- 0.77	Common Stock Shares Outstanding
Cash	- 0.76	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.75	Property Plant And Equipment Net
Other Current Assets	- 0.74	Total Assets